Treatment modality

Frequency

Neo-Adjuvant Chemotherapy

98%

MRM with ALND

90%

Toilet Mastectomy

7%

Adjuvant Radiotherapy

95%

5% develop metastatic disease during the course of neu-adjuvant chemo-therapy or after surgery

Hormonal treatment

60%